{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 1930"}, "official-title": {"#tail": "\n\t", "#text": "To prohibit the manufacture, marketing, sale, or shipment\n\t\t  in interstate commerce of products designed to assist in defrauding a drug\n\t\t  test."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130509", "#text": "May 9, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}, "sponsor": {"#tail": " (for\n\t\t\t himself and ", "#text": "Mr. Engel", "@name-id": "E000179"}, "cosponsor": {"#tail": ") introduced the\n\t\t\t following bill; which was referred to the ", "#text": "Mr. Terry", "@name-id": "T000459"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H81B10E5F662E47338820D2BB2F5D17F3", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Drug Testing Integrity Act of\n\t\t\t 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H80D2F00EAC4644C5B4917F2DA083F20C"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Ban of products\n\t\t\t designed to defraud drug tests"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "It shall be\n\t\t\t unlawful to knowingly manufacture, market, sell, ship, or otherwise provide to\n\t\t\t another individual any product with the intent to assist such other individual\n\t\t\t to use such product to defraud a drug test.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Conduct\n\t\t\t prohibited"}, "#text": "\n        ", "@id": "HA7C155D8FC7249F690A5E322B781B46D"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "defraud a drug test"}, "#text": "As\n\t\t\t used in this Act, the term "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Definition"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "submit a substance\n\t\t\t that purports to be from an individual other than its actual source, or\n\t\t\t purports to have been excreted or collected other than when it was actually\n\t\t\t excreted or collected; or"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HD53163038FF44328A07E55D3055AC61D", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "engage in any\n\t\t\t other conduct with the intent to produce a false or misleading outcome of a\n\t\t\t test for the presence of a controlled substance."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H070CEA4773644327B182072FD4B065E1", "#text": "\n          "}], "#text": "\n        ", "@id": "HB91715DC30FA451FAA264343DBA02991"}], "#text": "\n      ", "@id": "H96B1AA094D2C48E18466C0F525F13988"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Enforcement by\n\t\t\t the Federal Trade Commission"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be treated as a violation of a rule defining an\n\t\t\t unfair or deceptive act or practice prescribed under ", "@entity-type": "act", "#text": "section 2", "@value": "Drug Testing Integrity Act of 2013/s:2", "@proposed": "true"}, "#text": "A\n\t\t\t violation of ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 18(a)(1)(B) of the\n\t\t\t Federal Trade Commission Act", "@value": "Federal Trade Commission Act/s:18/ss:a/p:1/sp:B"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "15 U.S.C. 57a(a)(1)(B)", "@value": "usc/15/57a/a/1/B"}, "@parsable-cite": "usc/15/57a", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Unfair and\n\t\t\t deceptive act or practice"}, "#text": "\n        ", "@id": "HA33D6A4981D04A4BACB4AFC7F328CDC4"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall enforce this Act in\n\t\t\t the same manner, by the same means, and with the same jurisdiction as though\n\t\t\t all applicable terms and provisions of the ", "@entity-type": "federal-body", "#text": "Federal Trade Commission", "@entity-id": "2900"}, {"#tail": " were\n\t\t\t incorporated into and made a part of this Act.", "@entity-type": "act", "#text": "Federal Trade Commission Act", "@value": "Federal Trade Commission Act"}], "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Enforcement\n\t\t\t authority"}, "#text": "\n        ", "@id": "H12C9F6807ABC489A8B6E3BE88DA31255"}], "#text": "\n      ", "@id": "HCB08223468FB43C0B41092B9BCB064CB"}], "#text": "\n\t\t", "@id": "H0A3FD61855EB4C9FA16CE6ACB2D479EF"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-05-09"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 1930 IH: Drug Testing Integrity Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}